Yarrow Bioscience Q2 EPS $(2.14) Misses $(0.22) Estimate

Benzinga Newsdesk www.benzinga.com Negative 97.5%

Neg 97.5% Neu 0% Pos 0%

Yarrow Bioscience (NASDAQ:YARW) reported quarterly losses of $(2.14) per share which missed the analyst consensus estimate of $(0.22) by 872.73 percent.